Another treatment possibility for nmCRPC.
FDA approves darolutamide for non-met... - Advanced Prostate...
FDA approves darolutamide for non-metastatic castration-resistant prostate cancer
Written by
tango65
To view profiles and participate in discussions please or .
5 Replies
•
Erleada.
Zytiga, Xtandi, Erleada. I guess the next one will be called Ozmundi?
Now I just hope they come up with something new soon for mCRPC.
Not what you're looking for?
You may also like...
FDA Approves First PARP Inhibitor Rucaparib for BRCA-mutated metastatic castration-resistant prostate cancer
https://www.fda.gov/drugs/fda-grants-accelerated-approval-rucaparib-brca-mutated-metastatic-castrati
FDA Approves Darolutamide Plus Docetaxel for Metastatic Hormone-Sensitive Prostate Cancer
Other triple therapy approved by the FDA. The article has the basic results of the ARASENS trial....
Apalutamide for Metastatic Castration-Sensitive Prostate Cancer
Not surprising - question is the relative performance vs Abi or Enz (or combination with other...
Metastatic Prostate Cancer
Just started Zytiga, prednisone and hormone shots for recurrent prostate cancer that has returned...
Metastatic Castration-Resistant Prostate Cancer Pipeline: 75+ companies with 75+ pipeline drugs are involved
https://www.digitaljournal.com/pr/news/getnews/metastatic-castration-resistant-prostate-cancer-pipel